Living longer and living better: breast cancer endocrine therapy
- PMID: 30659045
- DOI: 10.1136/bmjspcare-2018-001666
Living longer and living better: breast cancer endocrine therapy
Keywords: aromatase inhibitors; breast cancer; quality of life; tamoxifen.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.N Engl J Med. 2018 Jul 12;379(2):122-137. doi: 10.1056/NEJMoa1803164. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863451 Free PMC article. Clinical Trial.
Similar articles
-
Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison.J Clin Pharm Ther. 2015 Feb;40(1):76-82. doi: 10.1111/jcpt.12227. Epub 2014 Nov 4. J Clin Pharm Ther. 2015. PMID: 25367863
-
Optimal adjuvant endocrine therapy for early breast cancer.Womens Health (Lond). 2010 May;6(3):383-98. doi: 10.2217/whe.10.25. Womens Health (Lond). 2010. PMID: 20426605 Review.
-
Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.Cancer. 2015 Jul 1;121(13):2147-55. doi: 10.1002/cncr.29332. Epub 2015 Mar 10. Cancer. 2015. PMID: 25757699 Free PMC article.
-
Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancer.Clin Breast Cancer. 2014 Jun;14(3):147-53. doi: 10.1016/j.clbc.2013.12.010. Epub 2013 Dec 27. Clin Breast Cancer. 2014. PMID: 24503025 Review.
-
Adherence to endocrine therapy for breast cancer.Oncology. 2006;71(1-2):1-9. doi: 10.1159/000100444. Epub 2007 Mar 5. Oncology. 2006. PMID: 17344666 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical